Ampol Limited (ALD.NZ)
NZD 32.04
(1.49%)
NZD 32.04
(1.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 40.64 Billion | 38.49 Billion | 21.42 Billion | 15.17 Billion | 22.05 Billion | 21.54 Billion |
| Cost of Revenue | 37.49 Billion | 35.67 Billion | 19.38 Billion | 14.2 Billion | 20.38 Billion | 19.6 Billion |
| Gross Profit | 3.15 Billion | 2.81 Billion | 2.03 Billion | 975.1 Million | 1.67 Billion | 1.93 Billion |
| Operating Expenses | 2.57 Billion | 2.18 Billion | 1.73 Billion | 2.02 Billion | 1.71 Billion | 1.55 Billion |
| Selling, General and Administrative Expenses | 2.07 Billion | 1.74 Billion | 1.35 Billion | 1.46 Billion | 1.32 Billion | 1.28 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 42.31 Million | 23.4 Million | 275.9 Million | 297.8 Million | 250.88 Million | 175.03 Million |
| Cost and Expenses | 36.73 Billion | 37.86 Billion | 21.12 Billion | 16.22 Billion | 22.1 Billion | 21.16 Billion |
| Operating Income | 998.1 Million | 1.04 Billion | 905.7 Million | -238.3 Million | 539.39 Million | 820.21 Million |
| Interest Expense | 227.52 Million | 116.5 Million | 58.2 Million | 52.5 Million | 62.39 Million | 51.87 Million |
| Income Tax Expense | 163.13 Million | 157.9 Million | 199.6 Million | -245.8 Million | 137.91 Million | 219.31 Million |
| Earnings before Tax | 809.3 Million | 936.5 Million | 797.1 Million | -725.6 Million | 521.73 Million | 780.9 Million |
| Net Income | 591.25 Million | 795.9 Million | 560 Million | -484.9 Million | 382.76 Million | 560.41 Million |
| Earnings Per Share Basic | 2.30 | 3.34 | 2.34 | -1.94 | 1.51 | 2.15 |
| Earnings Per Share Diluted | 2.30 | 3.32 | 2.34 | -1.94 | 1.51 | 2.15 |
| Weighted Average Shares Outstanding | 238.3 Million | 238.3 Million | 238.3 Million | 249.69 Million | 253 Million | 260.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 238.8 Million | 239.51 Million | 239.82 Million | 249.7 Million | 253.31 Million | 261 Million |
| Gross Margin | 0.08 | 0.07 | 0.09 | 0.06 | 0.08 | 0.09 |
| EBIT Margin | 0.04 | 0.04 | 0.06 | 0.02 | 0.04 | 0.05 |
| Profit Margin | 0.01 | 0.02 | 0.03 | -0.03 | 0.02 | 0.03 |
| EBITDA | 1.53 Billion | 1.49 Billion | 1.23 Billion | -113.4 Million | 971.48 Million | 1.08 Billion |
| Earnings Before Tax Margin | 0.02 | 0.03 | 0.04 | -0.02 | 0.02 | 0.04 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 9.65 Billion | 40.64 Billion | 9.65 Billion | 9.22 Billion | 9.22 Billion | 38.49 Billion |
| Cost of Revenue | 8.74 Billion | 37.49 Billion | 8.74 Billion | 8.66 Billion | 8.66 Billion | 35.67 Billion |
| Gross Profit | 903.45 Million | 3.15 Billion | 903.45 Million | 559.8 Million | 559.8 Million | 2.81 Billion |
| Operating Expenses | 509.1 Million | 2.57 Billion | 509.1 Million | 445.19 Million | 445.19 Million | 2.18 Billion |
| Selling, General and Administrative Expenses | 505.3 Million | - | 505.3 Million | 458.9 Million | 458.9 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 42.31 Million | - | - | - | 23.4 Million |
| Cost and Expenses | 9.25 Billion | 36.73 Billion | 9.25 Billion | 9.1 Billion | 9.1 Billion | 37.86 Billion |
| Operating Income | 397.9 Million | 998.1 Million | 397.9 Million | 101.15 Million | 101.15 Million | 1.04 Billion |
| Interest Expense | - | 227.52 Million | - | 155.81 Million | - | 116.5 Million |
| Income Tax Expense | 81.7 Million | 163.13 Million | 81.7 Million | 5.95 Million | 5.95 Million | 157.9 Million |
| Earnings before Tax | 329.65 Million | 809.3 Million | 329.65 Million | 46.15 Million | 46.15 Million | 936.5 Million |
| Net Income | 235 Million | 591.25 Million | 235 Million | 39.55 Million | 39.55 Million | 795.9 Million |
| Earnings Per Share Basic | 0.98 | - | 0.98 | 0.17 | 0.17 | - |
| Earnings Per Share Diluted | 0.98 | - | 0.98 | 0.17 | 0.17 | - |
| Weighted Average Shares Outstanding | 238.9 Million | 238.3 Million | 238.9 Million | 238.97 Million | 238.97 Million | 238.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 238.9 Million | 238.8 Million | 238.9 Million | 238.7 Million | 238.7 Million | 239.51 Million |
| Gross Margin | 0.09 | 0.08 | 0.09 | 0.06 | 0.06 | 0.07 |
| EBIT Margin | 0.05 | - | 0.05 | 0.02 | 0.02 | - |
| Profit Margin | 0.02 | 0.01 | 0.02 | 0.00 | 0.00 | 0.02 |
| EBITDA | 465.35 Million | - | 465.35 Million | 179.55 Million | 179.55 Million | - |
| Earnings Before Tax Margin | 0.04 | 0.02 | 0.04 | 0.01 | 0.01 | 0.03 |
RSI
7112
CLN
IVP
PCTY
MEDX